Sign up to save your podcasts
Or
Share Prof. dr. Bob Li
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Prof. dr. Bob Li
Prof. dr. Michael Boyer shares the results of the phase II CodeBreak 100 trial and discusses what these results mean for patients with non-small cell lung cancer harbouring G12C KRAS mutations
View all episodes
By Ariez PublishingProf. dr. Michael Boyer shares the results of the phase II CodeBreak 100 trial and discusses what these results mean for patients with non-small cell lung cancer harbouring G12C KRAS mutations